Attached files
| file | filename |
|---|---|
| 10-K - 10-K - EyePoint Pharmaceuticals, Inc. | eypt-10k_20191231.htm |
| EX-32.1 - EX-32.1 - EyePoint Pharmaceuticals, Inc. | eypt-ex321_6.htm |
| EX-32.2 - EX-32.2 - EyePoint Pharmaceuticals, Inc. | eypt-ex322_7.htm |
| EX-23.1 - EX-23.1 - EyePoint Pharmaceuticals, Inc. | eypt-ex231_10.htm |
| EX-31.2 - EX-31.2 - EyePoint Pharmaceuticals, Inc. | eypt-ex312_9.htm |
| EX-4.5 - EX-4.5 - EyePoint Pharmaceuticals, Inc. | eypt-ex45_389.htm |
| EX-10.32 - EX-10.32 - EyePoint Pharmaceuticals, Inc. | eypt-ex1032_519.htm |
| EX-31.1 - EX-31.1 - EyePoint Pharmaceuticals, Inc. | eypt-ex311_8.htm |
Exhibit 21.1
List of Subsidiaries of EyePoint Pharmaceuticals, Inc.
|
Subsidiary Name |
|
Jurisdiction of Incorporation |
|
EyePoint Pharmaceuticals US, Inc. |
|
Delaware |
|
pSiMedica Limited |
|
United Kingdom |
|
EyePoint Pharmaceuticals Securities Corporation |
|
Massachusetts |
|
Icon Bioscience, Inc. |
|
Delaware |